HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Catterall, W. A. Articles by Perez-Reyes, E. Search for Related Content PubMed PubMed Citation Articles by Catterall, W. A. Articles by Perez-Reyes, E.

International Union of Pharmacology. XL. Compendium of Voltage-Gated Ion Channels: Calcium Channels

Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington (W.A.C.); Abteilung Pharmakologie und Toxikologie, Institut für Pharmazie, Universität Innsbruck, Innsbruck, Austria (J.S.); Biotechnology Laboratory, University of British Columbia, Vancouver, British Columbia, Canada (T.P.S.); and Department of Pharmacology, University of Virginia, Charlottesville, Virginia (E.P.-R.)

Abstract

Calcium Channel Subunits

Calcium Currents

Calcium Channel Genes

Calcium Channel Molecular Pharmacology

	Abstract

Top Next

	Calcium Channel Subunits

Top Previous Next

 
Voltage-gated calcium channels mediate calcium influx in response to membrane depolarization and regulate intracellular processes such as contraction, secretion, neurotransmission, and gene expression. Their activity is essential to couple electrical signals in the cell surface to physiological events in cells. They are members of a gene superfamily of transmembrane ion channel proteins that includes voltage-gated potassium and sodium channels (Catterall, 1995).

The calcium channels that have been characterized biochemically are complex proteins composed of four or five distinct subunits, which are encoded by multiple genes (Fig. 1) (Catterall, 2000). The ₁ subunit of 190 to 250 kDa is the largest subunit, and it incorporates the conduction pore, the voltage sensor and gating apparatus, and the known sites of channel regulation by second messengers, drugs, and toxins. Like the subunits of sodium channels, the ₁ subunit of voltage-gated calcium channels is organized in four homologous domains (I–IV) with six transmembrane segments (S1–S6) in each. The S4 segment serves as the voltage sensor. The pore loop between transmembrane segments S5 and S6 in each domain determines ion conductance and selectivity, and changes of only three amino acids (aa) in the pore loops in domains I, III, and IV will convert a sodium channel to calcium selectivity. An intracellular subunit and a transmembrane, disulfide-linked ₂ subunit complex are components of most types of calcium channels. A subunit has also been found in skeletal muscle calcium channels and related subunits are expressed in heart and brain. Although these auxiliary subunits modulate the properties of the channel complex, the pharmacological and electrophysiological diversity of calcium channels arises primarily from the existence of multiple ₁ subunits (Hofmann et al., 1994).

View larger version (18K): [in this window] [in a new window]   FIG. 1. Subunits of CaV1 channels. The subunit composition and structure of calcium channels purified from skeletal muscle are illustrated. The model is updated from the original description of the subunit structure of skeletal muscle calcium channels. This model also fits available biochemical and molecular biological results for other CaV1 channels and for CaV2 channels. P, sites of phosphorylation by cAMP-dependent protein kinase; , sites of N-linked glycosylation. Predicted alpha helices are depicted as cylinders. The lengths of lines correspond approximately to the lengths of the polypeptide segments represented.

	Calcium Currents

Top Previous Next

 
Calcium currents recorded in different cell types have diverse physiological and pharmacological properties, and an alphabetical nomenclature has evolved for the distinct classes of calcium currents (Tsein et al., 1995). L-type calcium currents require a strong depolarization for activation, are long-lasting, and are blocked by the organic L-type calcium channel antagonists, including dihydropyridines, phenylalkylamines, and benzothiazepines. They are the main calcium currents recorded in muscle and endocrine cells, where they initiate contraction and secretion. N-type, P/Q-type, and R-type calcium currents also require strong depolarization for activation. They are relatively unaffected by L-type calcium channel antagonist drugs but are blocked by specific polypeptide toxins from snail and spider venoms. They are expressed primarily in neurons, where they initiate neurotransmission at most fast synapses and also mediate calcium entry into cell bodies and dendrites. T-type calcium currents are activated by weak depolarization and are transient. They are resistant to both organic antagonists and to the snake and spider toxins used to define the N- and P/Q-type calcium currents. They are expressed in a wide variety of cell types, where they are involved in shaping the action potential and controlling patterns of repetitive firing.

	Calcium Channel Genes

Top Previous Next

 
Mammalian ₁ subunits are encoded by at least ten distinct genes. Historically, various names had been given to the corresponding gene products, giving rise to distinct and sometimes confusing nomenclatures. In 1994, a unified but arbitrary nomenclature was adopted in which ₁ subunits were referred to as _1S for the original skeletal muscle isoform and _1A through _1E for those discovered subsequently (Birnbaumer et al., 1994). In 2000, a rational nomenclature was adopted based on the well defined potassium channel nomenclature (Chandy and Gutman, 1993; Ertel et al., 2000). Calcium channels were named using the chemical symbol of the principal permeating ion (Ca) with the principal physiological regulator (voltage) indicated as a subscript (Ca_V). The numerical identifier corresponds to the Ca_V channel ₁ subunit gene subfamily (1 to 3 at present) and the order of discovery of the ₁ subunit within that subfamily (1 through m). According to this nomenclature, the Ca_V1 subfamily (Ca_V1.1 to Ca_V1.4) includes channels containing _1S, _1C, _1D, and _1F, which mediate L-type Ca²⁺ currents (Table 1). The Ca_V2 subfamily (Ca_V2.1 to Ca_V2.3) includes channels containing _1A, _1B, and _1E, which mediate P/Q-, N-, and R-type Ca²⁺ currents, respectively (Table 1). The Ca_V3 subfamily (Ca_V3.1 to Ca_V3.3) includes channels containing _1G, _1H, and _1I, which mediate T-type Ca²⁺ currents.

The complete amino acid sequences of these ₁ subunits are more than 70% identical within a family but less than 40% identical among families. These family relationships are illustrated for the more conserved transmembrane and pore domains in Fig. 2. Division of calcium channels into these three families is phylogenetically ancient, as representatives of each are found in the Caenorhabditis elegans genome. Consequently, the genes for the different ₁ subunits have become widely dispersed in the genome and even the most closely related members of the family are not clustered on single chromosomes.

View larger version (28K): [in this window] [in a new window]   FIG. 2. Sequence similarity of voltage-gated calcium channel 1 subunits. Phylogenetic representation of the primary sequences of the calcium channels. Only the membrane-spanning segments and the pore loops (350 amino acids) are compared. First, all sequence pairs were compared, which clearly defines three families with intra-family sequence identities above 80% (CaV1, CaV2, CaV3). Then, a consensus sequence was defined for each family and these three sequences were compared with one another, with inter-family sequence identities of 52% (CaV1 versus CaV2) and 28% (CaV3 versus and CaV1 or CaV2).

	Calcium Channel Molecular Pharmacology

Top Previous Next

 
The pharmacology of the three families of calcium channel is quite distinct. The Ca_V1 channels are the molecular targets of the organic calcium channel blockers used widely in the therapy of cardiovascular diseases. These drugs are thought to act at three separate, but allosterically coupled, receptor sites (Table 1). Phenylalkylamines are intracellular pore blockers, which are thought to enter the pore from the cytoplasmic side of the channel and block it. Their receptor site is formed by amino acid residues in the S6 segments in domains III and IV, in close analogy to the local anesthetic receptor site on sodium channels (Hockerman et al., 1997; Hofmann et al., 1999; Striessnig, 1999). Dihydropyridines can be channel activators or inhibitors and therefore are thought to act allosterically to shift the channel toward the open or closed state, rather than by occluding the pore. Their receptor site includes amino acid residues in the S6 segments of domains III and IV and the S5 segment of domain III. The dihydropyridine receptor site is closely apposed to the phenylalkylamine receptor site and shares some common amino acid residues. Diltiazem and related benzothiazepines are thought to bind to a third receptor site, but the amino acid residues that are required for their binding overlap extensively with those required for phenylalkylamine binding.

The Ca_V2 family of calcium channels is relatively insensitive to dihydropyridine calcium channel blockers, but these calcium channels are specifically blocked with high affinity by peptide toxins from spiders and marine snails (Miljanich and Ramachandran, 1995). The Ca_V2.1 channels are blocked specifically by -agatoxin IVA from funnel web spider venom. The Ca_V2.2 channels are blocked specifically by -conotoxin GVIA and related cone snail toxins. The Ca_V2.3 channels are blocked specifically by the synthetic peptide toxin SNX-482 derived from tarantula venom. These peptide toxins are potent blockers of synaptic transmission because of their specific effects on the Ca_V2 family of calcium channels.

The Ca_V3 family of calcium channels is insensitive to both the dihydropyridines that block Ca_V1 channels and the spider and cone snail toxins that block the Ca_V2 channels, and there are no widely useful pharmacological agents that block T-type calcium currrents (Heady et al., 2001). The organic calcium channel blockers mibefradil is somewhat specific for T-type versus L-type calcium currents (3- to 5-fold). The peptide kurtoxin inhibits the activation gating of Ca_V3.1 and Ca_V3.2 channels. Development of more specific and high affinity blockers of the Ca_V3 family of calcium channels would be useful for therapy and for more detailed analysis of the physiological roles of these channels.

This section of the compendium summarizes the major molecular, physiological, and pharmacological properties for each of the ten calcium channels that have been functionally expressed. Quantitative data are included for voltage dependence of activation and inactivation, single-channel conductance, and binding of drugs and neurotoxins, focusing on those agents that are widely used and are diagnostic of channel identity and function.

	Footnotes

 
Address correspondence to: Dr. William A. Catterall, Department of Pharmacology, University of Washington School of Medicine, Box 357280, Seattle, WA 98195-7280. E-mail: wcatt{at}u.washington.edu

DOI: 10.1124/pr.55.4.8.

¹ This work was previously published in Catterall WA, Chandy KG, and Gutman GA, eds. (2002) The IUPHAR Compendium of Voltage-Gated Ion Channels, International Union of Pharmacology Media, Leeds, UK.

	References

Top

 

Birnbaumer L, Campbell KP, Catterall WA, Harpold MM, Hofmann F, Horne WA, Mori Y, Schwartz A, Snutch TP, Tanabe T, et al. (1994) The naming of voltage-gated calcium channels. Neuron 13: 505-506.[CrossRef][Medline]

Catterall WA (1995) Structure and function of voltage-gated ion channels. Annu Rev Biochem 65: 493-531.[CrossRef]

Catterall WA (2000) Structure and regulation of voltage-gated Ca²⁺ channels. Annu Rev Cell Dev Biol 16: 521-555.[CrossRef][Medline]

Chandy KG and Gutman GA (1993) Nomenclature for mammalian potassium channel genes. Trends Pharmacol Sci 14: 434.[CrossRef][Medline]

Ertel EA, Campbell KP, Harpold MM, Hofmann F, Mori Y, Perez-Reyes E, Schwartz A, Snutch TP, Tanabe T, Birnbaumer L, et al. (2000) Nomenclature of voltage-gated calcium channels. Neuron 25: 533-535.[CrossRef][Medline]

Glossmann H and Striessnig J (1990) Molecular properties of calcium channels. Rev Physiol Biochem Pharmacol 114: 1-105.[Medline]

Heady TN, Gomora JC, Macdonald TL, and Perez-Reyes E (2001) Molecular pharmacology of T-type Ca²⁺ channels. Jpn J Pharmacol 85: 339-350.[CrossRef][Medline]

Hockerman GH, Peterson BZ, Johnson BD, and Catterall WA (1997) Molecular determinants of drug binding and action on L-type calcium channels. Annu Rev Pharmacol Toxicol 37: 361-396.[CrossRef][Medline]

Hofmann F, Biel M, and Flockerzi V (1994) Molecular basis for Ca²⁺ channel diversity. Annu Rev Neurosci 17: 399-418.[CrossRef][Medline]

Hofmann F, Lacinová L, and Klugbauer N (1999) Voltage-dependent calcium channels: from structure to function. Rev Physiol Biochem Pharmacol 139: 33-87.[Medline]

Miljanich GP and Ramachandran J (1995) Antagonists of neuronal calcium channels: structure, function, and therapeutic implications. Annu Rev Pharmacol Toxicol 35: 707-734.[CrossRef][Medline]

Striessnig J (1999) Pharmacology, structure and function of cardiac L-type calcium channels. Cell Physiol Biochem 9: 242-269.[Medline]

Tsien RW, Lipscombe D, Madison D, Bley K, and Fox A (1995) Reflections on calcium channel diversity, 1988–1994. Trends Neurosci 18: 52-54.[CrossRef][Medline]

This article has been cited by other articles:

				S. Ellefsen, G. K. Sandvik, H. K. Larsen, K.-O. Stenslokken, D. A. S. Hov, T. A. Kristensen, and G. E. Nilsson Expression of genes involved in excitatory neurotransmission in anoxic crucian carp (Carassius carassius) brain Physiol Genomics, September 17, 2008; 35(1): 5 - 17. [Abstract] [Full Text] [PDF]

				M. E. Mangoni and J. Nargeot Genesis and Regulation of the Heart Automaticity Physiol Rev, July 1, 2008; 88(3): 919 - 982. [Abstract] [Full Text] [PDF]

				G. Chung, J.N. Rhee, S.J. Jung, J.S. Kim, and S.B. Oh Modulation of CaV2.3 Calcium Channel Currents by Eugenol J. Dent. Res., February 1, 2008; 87(2): 137 - 141. [Abstract] [Full Text] [PDF]

				B. K. Rycroft, K. S. Vikman, and M. J. Christie Inflammation reduces the contribution of N-type calcium channels to primary afferent synaptic transmission onto NK1 receptor-positive lamina I neurons in the rat dorsal horn J. Physiol., May 1, 2007; 580(3): 883 - 894. [Abstract] [Full Text] [PDF]

				G. Baroudi, Y. Qu, O. Ramadan, M. Chahine, and M. Boutjdir Protein kinase C activation inhibits Cav1.3 calcium channel at NH2-terminal serine 81 phosphorylation site. Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1614 - H1622. [Abstract] [Full Text] [PDF]

				M. C. Chen, S. V. Wu, J. R. Reeve Jr., and E. Rozengurt Bitter stimuli induce Ca2+ signaling and CCK release in enteroendocrine STC-1 cells: role of L-type voltage-sensitive Ca2+ channels Am J Physiol Cell Physiol, October 1, 2006; 291(4): C726 - C739. [Abstract] [Full Text] [PDF]

				R. Johnson, R. J. Gamblin, L. Ooi, A. W. Bruce, I. J. Donaldson, D. R. Westhead, I. C. Wood, R. M. Jackson, and N. J. Buckley Identification of the REST regulon reveals extensive transposable element-mediated binding site duplication Nucleic Acids Res., September 1, 2006; 34(14): 3862 - 3877. [Abstract] [Full Text] [PDF]

				T.-S. Lee, R. Karl, S. Moosmang, P. Lenhardt, N. Klugbauer, F. Hofmann, T. Kleppisch, and A. Welling Calmodulin Kinase II Is Involved in Voltage-dependent Facilitation of the L-type Cav1.2 Calcium Channel: IDENTIFICATION OF THE PHOSPHORYLATION SITES J. Biol. Chem., September 1, 2006; 281(35): 25560 - 25567. [Abstract] [Full Text] [PDF]

				E. Rozengurt Taste Receptors in the Gastrointestinal Tract. I. Bitter taste receptors and {alpha}-gustducin in the mammalian gut Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G171 - G177. [Abstract] [Full Text] [PDF]

				R. A. Anderson, K. A. Feathergill, D. P. Waller, and L. J. D. Zaneveld SAMMA Induces Premature Human Acrosomal Loss by Ca2+ Signaling Dysregulation J Androl, July 1, 2006; 27(4): 568 - 577. [Abstract] [Full Text] [PDF]

				Y.-J. Won, K. Whang, I. D. Kong, K.-S. Park, J.-W. Lee, and S.-W. Jeong Expression Profiles of High Voltage-Activated Calcium Channels in Sympathetic and Parasympathetic Pelvic Ganglion Neurons Innervating the Urogenital System J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1064 - 1071. [Abstract] [Full Text] [PDF]

				J. Hall, R. D. Jones, T. H. Jones, K. S. Channer, and C. Peers Selective Inhibition of L-Type Ca2+ Channels in A7r5 Cells by Physiological Levels of Testosterone Endocrinology, June 1, 2006; 147(6): 2675 - 2680. [Abstract] [Full Text] [PDF]

				C. Jimenez-Gonzalez, F. Michelangeli, C.V. Harper, C.L.R. Barratt, and S.J. Publicover Calcium signalling in human spermatozoa: a specialized 'toolkit' of channels, transporters and stores Hum. Reprod. Update, May 1, 2006; 12(3): 253 - 267. [Abstract] [Full Text] [PDF]

				A. Hohaus, S. Beyl, M. Kudrnac, S. Berjukow, E. N. Timin, R. Marksteiner, M. A. Maw, and S. Hering Structural Determinants of L-type Channel Activation in Segment IIS6 Revealed by a Retinal Disorder J. Biol. Chem., November 18, 2005; 280(46): 38471 - 38477. [Abstract] [Full Text] [PDF]

				B. Liu, S. J. Hill, and R. N. Khan Oxytocin Inhibits T-Type Calcium Current of Human Decidual Stromal Cells J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4191 - 4197. [Abstract] [Full Text] [PDF]

				I. L. White, N. P. Franks, and R. Dickinson Effects of isoflurane and xenon on Ba2+-currents mediated by N-type calcium channels Br. J. Anaesth., June 1, 2005; 94(6): 784 - 790. [Abstract] [Full Text] [PDF]

				R. Felix Molecular physiology and pathology of Ca2+-conducting channels in the plasma membrane of mammalian sperm Reproduction, March 1, 2005; 129(3): 251 - 262. [Abstract] [Full Text] [PDF]

				S. P. Brown, P. K. Safo, and W. G. Regehr Endocannabinoids Inhibit Transmission at Granule Cell to Purkinje Cell Synapses by Modulating Three Types of Presynaptic Calcium Channels J. Neurosci., June 16, 2004; 24(24): 5623 - 5631. [Abstract] [Full Text] [PDF]

				L. Stokes, J. Gordon, and G. Grafton Non-voltage-gated L-type Ca2+ Channels in Human T Cells: PHARMACOLOGY AND MOLECULAR CHARACTERIZATION OF THE MAJOR {alpha} PORE-FORMING AND AUXILIARY {beta}-SUBUNITS J. Biol. Chem., May 7, 2004; 279(19): 19566 - 19573. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Catterall, W. A. Articles by Perez-Reyes, E. Search for Related Content PubMed PubMed Citation Articles by Catterall, W. A. Articles by Perez-Reyes, E.